Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial

✍ Scribed by Nicholas D. James; Armelle Caty; Michael Borre; Bernard A. Zonnenberg; Philippe Beuzeboc; Thomas Morris; De Phung; Nancy A. Dawson

• Book ID: 113611182
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 1000 KB
• Volume: 55
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2008.11.002